Vaccine use in primary immunodeficiency disorders

Area of Science:

• Immunology
• Genetics
• Infectious Diseases

Background:

• Primary immunodeficiency disorders (PIDs) are rare genetic conditions causing immune system defects.
• Individuals with PIDs exhibit heightened susceptibility to infections, impacting prognosis.
• Current treatments include immunoglobulin replacement, antibiotics, and antifungals.

Purpose of the Study:

• To review current knowledge on vaccine use in PID patients.
• To guide clinicians in making informed decisions about vaccination strategies.
• To optimize patient protection while minimizing vaccine-related risks.

Main Methods:

• Literature review on PIDs and vaccine efficacy/safety.
• Analysis of immune responses to vaccines in different PID types.
• Evaluation of risks associated with live vaccines in immunocompromised individuals.

Main Results:

• Vaccine efficacy varies significantly among PID types.
• Some PIDs mount normal immune responses to vaccines.
• Other PIDs show impaired responses, with risks of adverse events, especially with live vaccines.

Conclusions:

• Vaccination strategies must be tailored to the specific PID type and immune status.
• Careful consideration of vaccine type and potential risks is crucial.
• Informed decision-making is essential for effective infection prophylaxis in PID patients.